Baseline immune signature scores of peripheral blood predict outcome to checkpoint inhibitor therapy in cancer patients

被引：0
|
作者：
Hattenhauer, S. T. [1 ]
Mispelbaum, R. [1 ]
Held, S. A. E. [1 ]
Marques, Palma L. [1 ]
Brossart, P. [1 ]
Heine, A. [1 ]
机构：
[1] Univ Hosp Bonn, Dept Oncol Hematol Immune Oncol & Rheumatol, Bonn, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1112
引用
下载
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [1] Peripheral blood mononuclear cell biomarkers predict response to immune checkpoint inhibitor therapy in metastatic breast cancer
    Yuan, Y.
    Hou, W.
    Padam, S.
    Frankel, P.
    Sedrak, M. S.
    Portnow, J.
    Mortimer, J.
    Yeon, C.
    Hurria, A.
    Tang, A.
    Martinez, N.
    Lee, P.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Predictive immune signatures in peripheral blood of patients undergoing checkpoint inhibitor therapy
    Kwong, Chun-Ting
    McGuire, Helen
    de St Groth, Barbara Fazekas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 60 - 60
  • [3] Cachectic Cancer Patients: Immune to Checkpoint Inhibitor Therapy?
    Coss, Christopher C.
    Clinton, Steven K.
    Phelps, Mitch A.
    CLINICAL CANCER RESEARCH, 2018, 24 (23) : 5787 - 5789
  • [4] Baseline Tumor Immune Cell Infiltration and Activation can Predict Checkpoint Inhibitor Pneumonitis in Lung Cancer Patients
    Bracht, J.
    Viteri, S.
    Aguilar, A.
    Garcia, J. J.
    Huang, C.
    Potie, N.
    Aldeguer, E.
    Gimenez-Capitan, A.
    Rodriguez, S.
    Roman, R.
    Warren, S.
    Rosell, R.
    Molina-Vila, M. A.
    Gonzalez-Cao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S546 - S546
  • [5] Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer
    Yang, Zhenyu
    Wei, Shiyou
    Liu, Lunxu
    JAMA ONCOLOGY, 2020, 6 (04) : 587 - 587
  • [6] Genomic alterations in SPEN predict outcome of immune checkpoint therapy in gastrointestinal cancer
    Wu, C.
    Qiao, X.
    Gong, D.
    Li, S.
    Yu, Z.
    Liu, Y.
    Zhang, Q.
    Chen, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S449 - S449
  • [7] Developing an immune signature for triple-negative breast cancer to predict prognosis and immune checkpoint inhibitor response
    Wang, Ce
    Feng, Guoshuang
    Zhu, Jingjing
    Wei, Kecheng
    Huang, Chen
    Wu, Zhenyu
    Yu, Yongfu
    Qin, Guoyou
    FUTURE ONCOLOGY, 2022, 18 (09) : 1055 - 1066
  • [8] Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
    Lee, Juwon
    Han, Youngjin
    Wang, Wenyu
    Jo, HyunA
    Kim, Heeyeon
    Kim, Soochi
    Yang, Kyung-Min
    Kim, Seong-Jin
    Dhanasekaran, Danny N.
    Song, Yong Sang
    BIOMOLECULES, 2021, 11 (08)
  • [9] Immune Checkpoint Inhibitor Therapy in Breast Cancer
    Santa-Maria, Cesar A.
    Nanda, Rita
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (10): : 1259 - 1268
  • [10] Cutaneous toxicities in lung cancer patients on immune checkpoint inhibitor therapy
    Keiser, Monika
    Patel, Anisha B.
    Altan, Mehmet
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB75 - AB75
12345